Truist raises Glaukos price target to $255
The raised target implies substantial upside, though it remains an analyst opinion rather than a confirmed catalyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The raised target implies substantial upside, though it remains an analyst opinion rather than a confirmed catalyst.
What happened, with direct paths to the underlying reporting
Truist raised its price target on GKOS to $255, about 41% above the posted price of $181.43.
Target: $255
Posted price: $181.43
Analyst firm: Truist Financial
Analyst: Richard Newitter
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.